Literature DB >> 7688484

Enhanced type III collagen gene expression during bleomycin induced lung fibrosis.

S Shahzeidi1, B Mulier, B de Crombrugghe, P K Jeffery, R J McAnulty, G J Laurent.   

Abstract

BACKGROUND: Intratracheal instillation of bleomycin into mice leads to deposition of collagen in the lung and fibrosis, but the mechanism for this is poorly understood. Enhanced collagen gene expression, increased collagen synthesis, decreased collagen degradation, and proliferation of fibroblasts have all been proposed as possible contributors. To obtain information on the activity of collagen producing cells at an early stage in the development of pulmonary fibrosis in situ hybridisation was used to detect and localise products of the type III procollagen gene. In addition, assay of type III procollagen gene expression was performed using dot-blot analysis of lung RNA extracts.
METHODS: Lung fibrosis was induced in mice by intratracheal instillation of bleomycin sulphate (6 mg/kg body weight) and tissues were examined after three, 10, 21 and 35 days. RNA-RNA hybridisation was accomplished with riboprobes labelled with sulphur-35 which were generated from a 1.7 kb mouse procollagen a1(III) cDNA. In situ hybridisation was performed on sections fixed in paraformaldehyde and embedded in paraffin wax and steady state values of type III procollagen mRNA were assayed by dot-blot analysis of total lung RNA extracted by guanidium isothiocyanate.
RESULTS: Data obtained using both techniques suggest that type III procollagen gene expression was enhanced in bleomycin induced fibrosis and that expression was maximal between 10 and 35 days after a single dose of bleomycin. The most active cells were located in interstitial areas around the conducting airways, although these cells were usually seen in areas with no histological evidence of fibrosis. Regions with the most advanced fibrosis, as assessed by histological methods, rarely contained cells with activity above the threshold detectable by this technique.
CONCLUSIONS: These results suggest that activation of interstitial fibroblasts, with enhanced type III collagen gene expression, forms at least part of the mechanism leading to increased collagen deposition in bleomycin induced fibrosis and that this occurs before fibrosis is detected by conventional histological staining.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688484      PMCID: PMC464587          DOI: 10.1136/thx.48.6.622

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  21 in total

1.  Enhanced collagen production by smooth muscle cells during repetitive mechanical stretching.

Authors:  B E Sumpio; A J Banes; W G Link; G Johnson
Journal:  Arch Surg       Date:  1988-10

2.  Demonstration of tissue-specific gene expression by in situ hybridization.

Authors:  L M Angerer; K H Cox; R C Angerer
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue.

Authors:  M Jordana; J Schulman; C McSharry; L B Irving; M T Newhouse; G Jordana; J Gauldie
Journal:  Am Rev Respir Dis       Date:  1988-03

4.  Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis.

Authors:  R Raghow; S Lurie; J M Seyer; A H Kang
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

5.  Bleomycin selectively elevates mRNA levels for procollagen and fibronectin following acute lung injury.

Authors:  J Kelley; L Chrin; S Shull; D W Rowe; K R Cutroneo
Journal:  Biochem Biophys Res Commun       Date:  1985-09-16       Impact factor: 3.575

6.  Lung cytokine production in bleomycin-induced pulmonary fibrosis.

Authors:  S H Phan; S L Kunkel
Journal:  Exp Lung Res       Date:  1992 Jan-Mar       Impact factor: 2.459

7.  Biochemical evidence for an increased and progressive deposition of collagen in lungs of patients with pulmonary fibrosis.

Authors:  J M Kirk; P E Da Costa; M Turner-Warwick; R J Littleton; G J Laurent
Journal:  Clin Sci (Lond)       Date:  1986-01       Impact factor: 6.124

8.  Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice.

Authors:  D G Hoyt; J S Lazo
Journal:  J Pharmacol Exp Ther       Date:  1988-08       Impact factor: 4.030

9.  Quantitation of types I and III collagen in biopsy lung samples from patients with cryptogenic fibrosing alveolitis.

Authors:  J M Kirk; B E Heard; I Kerr; M Turner-Warwick; G J Laurent
Journal:  Coll Relat Res       Date:  1984-05

10.  A molecular analysis of mouse development from 8 to 10 days post coitum detects changes only in embryonic globin expression.

Authors:  D G Wilkinson; J A Bailes; J E Champion; A P McMahon
Journal:  Development       Date:  1987-04       Impact factor: 6.868

View more
  13 in total

1.  Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis.

Authors:  N Kaminski; J D Allard; J F Pittet; F Zuo; M J Griffiths; D Morris; X Huang; D Sheppard; R A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  FIZZ1 stimulation of myofibroblast differentiation.

Authors:  Tianju Liu; Saravana M Dhanasekaran; Hong Jin; Biao Hu; Scott A Tomlins; Arul M Chinnaiyan; Sem H Phan
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

3.  Discoidin Domain Receptor 2 Signaling Regulates Fibroblast Apoptosis through PDK1/Akt.

Authors:  Shijing Jia; Manisha Agarwal; Jibing Yang; Jeffrey C Horowitz; Eric S White; Kevin K Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2018-09       Impact factor: 6.914

4.  Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis.

Authors:  R K Coker; G J Laurent; S Shahzeidi; P A Lympany; R M du Bois; P K Jeffery; R J McAnulty
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

5.  Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation.

Authors:  Jean-Marie Forel; Christophe Guervilly; Sami Hraiech; François Voillet; Guillemette Thomas; Claude Somma; Véronique Secq; Catherine Farnarier; Marie-Josée Payan; Stéphanie-Yannis Donati; Gilles Perrin; Delphine Trousse; Stéphanie Dizier; Laurent Chiche; Karine Baumstarck; Antoine Roch; Laurent Papazian
Journal:  Intensive Care Med       Date:  2014-10-30       Impact factor: 17.440

6.  Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis.

Authors:  R E Swiderski; J E Dencoff; C S Floerchinger; S D Shapiro; G W Hunninghake
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

7.  Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis.

Authors:  Thomas C Beller; Daniel S Friend; Akiko Maekawa; Bing K Lam; K Frank Austen; Yoshihide Kanaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-17       Impact factor: 11.205

8.  MicroRNA let-7 Downregulates Ligand-Independent Estrogen Receptor-mediated Male-Predominant Pulmonary Fibrosis.

Authors:  Sharon Elliot; Simone Periera-Simon; Xiaomei Xia; Paola Catanuto; Gustavo Rubio; Shahriar Shahzeidi; Fadi El Salem; Josh Shapiro; Karoline Briegel; Kenneth S Korach; Marilyn K Glassberg
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

9.  Expression profiling of genes regulated by Fra-1/AP-1 transcription factor during bleomycin-induced pulmonary fibrosis.

Authors:  Subbiah Rajasekaran; Narsa M Reddy; Wei Zhang; Sekhar P Reddy
Journal:  BMC Genomics       Date:  2013-06-07       Impact factor: 3.969

10.  Hirsutella sinensis mycelium attenuates bleomycin-induced pulmonary inflammation and fibrosis in vivo.

Authors:  Tsung-Teng Huang; Hsin-Chih Lai; Yun-Fei Ko; David M Ojcius; Ying-Wei Lan; Jan Martel; John D Young; Kowit-Yu Chong
Journal:  Sci Rep       Date:  2015-10-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.